ReviewFoods (Basel, Switzerland)2026
Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Global population growth and the demand for sustainable food systems have pushed microalgae into the spotlight as promising novel food resources. They are rich in protein, omega-3 fatty acids, and bioactive pigments including astaxanthin and phycocyanin. Unlike conventional farming, microalgae cultivation can be conducted on non-arable land and may reduce direct competition with conventional food crops for land resources, depending on the production system used. Regulatory progress in China, the European Union (EU), and the United States has resulted in the authorization or approval of several microalgal species and microalgae-derived ingredients for specific food and nutritional applications, including dietary supplements, infant nutrition products, and alternative protein ingredients. Despite these advances, broader commercial adoption remains constrained by several challenges, such as off-flavors and the dark green color, high production costs from closed photobioreactors and energy-intensive downstream purification, fragmented regulatory frameworks across jurisdictions and limited long-term data on bioavailability, allergenicity, safety, and dose-response relationships for some emerging strains. This review focuses on microalgae as novel food resources, covering regulatory approvals, strain selection, high-value utilization, and market translation, synthesizes evidence on nutritional evaluation, application scenarios, and global regulatory differences, analyzes key bottlenecks, and proposes pathways to bridge fundamental research with industrial practice. It also highlights unresolved knowledge gaps to guide future research and policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.